MedTrace Logo

A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT03979807 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11296

Last updated 2021-11-15

Study results available
· View outcomes & findings →

Summary

To compare the persistence in using two different medications from the same drug class (LAMA/LABA FDC) which are delivered through different devices, a dry-powder inhalers (DPI) and Soft Mist Inhalers (SMI).

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Olodaterol/Tiotropium Bromide

(Stiolto®) delivered via Respimat inhaler

DRUG

Umeclidinium/ Vilanterol

(Anoro®) delivered via Ellipta Inhaler

Sponsors & Collaborators

Eligibility

Min Age
1 Year
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-10
Primary Completion
2019-06-11
Completion
2019-06-11
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03979807 on ClinicalTrials.gov